Triangle startup Pairwise strikes genome editing deal with MIT-Harvard institute
RESEARCH TRIANGLE PARK, N.C. – Pairwise, one of the Triangle area’s fast-growing agriculture and food biotech companies, has licensed some advanced CRISPR genome editing technologies from two prestigious Boston institutions to expand its crop-editing applications and bring new foods to market. Pairwise, which operates a site in Durham’s Golden Belt and greenhouses in Research Triangle Park, has entered into licensing agreements with Massachusetts General Hospital (MGH) and the Broad Institute of MIT and Harvard (Broad Institute) for their latest CRISPR genome editing...
Read MoreVirginia Bio CEO Jeff Gallagher Stepping Down
RICHMOND, VA. – Virginia Bio, the statewide non-profit trade association for the life science industry, announced today that after seven years of service Jeff Gallagher CEO will step down from his position as CEO later this year, then will continue to serve the association on select special projects. A national search for a new CEO will begin immediately, conducted by the Virginia Bio Board of Directors. Under Mr. Gallagher’s leadership, Virginia Bio has prioritized service to its many members, built important new collaborations, woven together the state’s diverse and dynamic...
Read MorevTv Therapeutics Announces $15 Million of Class A Common Stock Financings
HIGH POINT, N.C. – -vTv Therapeutics Inc. (Nasdaq:VTVT) (the “Company”) today announced that it has entered into a definitive agreement with certain institutional investors for the purchase and sale in a registered direct offering (the “Registered Direct Offering”) of 3,636,364 shares of the Company’s Class A common stock (the “Common Stock”) at a price of $1.65 per share for aggregate gross proceeds of approximately $6.0 million. The offering is expected to close on or about March 20, 2019, subject to the satisfaction of customary closing conditions. H.C. Wainwright...
Read MoreAdvantage Capital Invests $6.5 Million in Danimer Scientific, Supporting Company’s Growth in Rural Georgia
NEW ORLEANS, LA. & BAINBRIDGE, GA. – Advantage Capital today announced a $6.5 million investment in Danimer Scientific, a leading biotechnology company producing biodegradable and compostable polymers used in consumer and industrial products. The investment was made through the GARJA program and supports the company’s anticipated growth as it seeks to boost capacity and significantly increase its workforce at its Bainbridge, GA location over the next few years. “The Georgia Agribusiness and Rural Jobs Act was created to bring investment capital and jobs to the more rural parts...
Read MoreCresco Labs Enters Florida
CHICAGO, IL. & JACKSONVILLE, FL. – Cresco Labs Inc. (“Cresco Labs” or the “Company”) (CSE: CL) (OTCQX: CRLBF), one of the largest vertically integrated multistate cannabis operators in the United States, today announced that it is entering the Florida market through the signing of a letter agreement to acquire the ownership interests or assets of VidaCann Ltd. and/or affiliated entities (“VidaCann”), one of the largest and most advanced providers of medical cannabis in Florida (the “Transaction”). Key Transaction Highlights and Benefits: Vertically Integrated...
Read MoreFrench cancer research firm to build plant in Raleigh
A French biomedical firm that uses gene-editing technology to develop cancer treatments, plans to invest $68 million in a Raleigh plant, officials said Thursday. Cellectis will hire up to 200 people for the plant, which will be the company’s first North American manufacturing operation. Founded in 1999, Cellectis takes healthy donor T-cells and uses gene editing to create “off-the-shelf” products for cancer patients, Bill Monteith, who will oversee the plant, said during a news conference at the State Capitol. The state approved a Job Development Investment Grant for the company that...
Read More
Follow Us!